Pharmaceutical Executive, Mar 1, 2012 - Pharmaceutical Executive

ADVERTISEMENT

Pharmaceutical Executive, Mar 1, 2012
Features
Novartis: LEADing in Emerging Markets
By William Looney
With growth as its guiding light, Novartis has big plans for the emerging markets. Pharm Exec sits down with CEO Joe Jimenez to understand what it will take the company to best the competition.
The (Life) Science of Digital Connections
By Jennifer Ringler , Ben Comer
Making real connections that resonate with audiences in a digital world is a fine art, especially in the heavily regulated world of Big Pharma
Off the Hook? Pharm Exec's Annual Press Audit
By George P. Sillup , Stephen J. Porth
Our annual press audit finds that the big news in 2011 for pharma was ... no news.
From the Editor
The Maestros
By William Looney
Pharm Exec's latest EAB meeting offered a frank exchange on this magazine's digital future.
Column
When Talk is Not So Cheap
By Jill Wechsler
FDA and industry are pushing user fees, while they struggle with curbs on communications.
Back Page
Betting on Bigger Data
By Ben Comer
In the rush to collect as much patient data as possible, are we sacrificing quality for quantity? Ben Comer reports.
Regulatory
How Can We Fix the FDA?
How can we better balance addressing medical needs with ensuring that new drugs are safe and effective? Ron Cohen reports.
European Report
The Italian's Job
By Reflector
After his predecessor and countryman left the EMA in disgrace, Guido Rasi jumps in as executive director—with great challenges ahead.
Marketing
Judging a Pill by its Cover
Pharmaceutical trade dres is an effective marketing tool that helps boost product recognition for consumers. It's worth protecting.

ADVERTISEMENT

Click here